IMCR - Immunocore GAAP EPS of -$4.19 misses by $0.18 revenue of $35.8M March, 03 2022 07:30 AM Immunocore Holdings plc Immunocore press release (NASDAQ:IMCR): FY GAAP EPS of -$4.19 misses by $0.18. Revenue of $35.8M (-12% Y/Y). For further details see: Immunocore GAAP EPS of -$4.19 misses by $0.18, revenue of $35.8M